@article{oai:nagoya.repo.nii.ac.jp:00022952,
 author = {Brodowska-Kania, Dorota and Kotwica, Ewa and Paturej, Aleksandra and Sośnicki, Witold and Patera, Janusz and Giżewska, Agnieszka and Niemczyk, Stanisław},
 issue = {4},
 journal = {Nagoya Journal of Medical Science},
 month = {Nov},
 note = {Pulmonary blastoma (PB) is a rare form of lung tumour and is accountable for 0.25–0.5% of primary pulmonary malignancies. Initially pulmonary blastoma was divided into three subtypes: biphasic pulmonary blastoma (BPB) consisting of an epithelial and mesenchymal component, well differentiated fetal adenocarcinoma (WDFA) built of well differentiated epithelium and a mesenchymal component and malignant pleuropulmonary blastoma (PPB). Prognosis in this type of cancer is really poor. We present a current review of literature and a clinical case report. Treatment of PB is very difficult. Data and recommendations about the treatment of pulmonary blastoma are still available therefore we should use only observations and clinical case reports.},
 pages = {507--516},
 title = {What do we know about pulmonary blastoma? : review of literature and clinical case report},
 volume = {78},
 year = {2016}
}